| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/22/2012 | EP2419094A1 Compounds for the treatment of mitochondrial diseases |
| 02/22/2012 | EP2419093A2 Methods of reduction of interpatient variability |
| 02/22/2012 | EP2419092A2 Pharmaceutical composition for treating dermatological autoimmune diseases |
| 02/22/2012 | EP2419090A1 Bioavailable capsule compositions of amorphous alpha-(n-sulfonamido)acetamide compound |
| 02/22/2012 | EP2419087A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it |
| 02/22/2012 | EP2419084A2 A medicinal cream made using clotrimazole and chitosan and a process to make the same |
| 02/22/2012 | EP2419083A2 A medicinal cream made using silver sulphadiazine and chitosan and a process to make it |
| 02/22/2012 | EP2419082A2 Topical pharmaceutical composition containing a water-sensitive active principle |
| 02/22/2012 | EP2419081A1 Aqueous ophthalmic compositions containing anionic therapeutic agents |
| 02/22/2012 | EP2418972A1 High fiber nutritional emulsions for blood glucose control |
| 02/22/2012 | EP2418971A1 Trehalulose-containing composition, its preparation and use |
| 02/22/2012 | EP2418965A1 Hydroxytyrosol combinations for enhancing mitochondrial function and energy production |
| 02/22/2012 | EP2418962A1 Use of conjugated linoleic acid |
| 02/22/2012 | EP2418961A1 Milk oligosaccharide compositions and use thereof in treating infection in animals |
| 02/22/2012 | EP2418956A1 Method of treating hepatocellular carcinoma |
| 02/22/2012 | EP2418955A1 High bioavailability oral picoplatin anti-cancer therapy |
| 02/22/2012 | EP2418950A1 Compounds and methods for modulating activity of calcium release channels |
| 02/22/2012 | EP2418949A1 Methods and compositions for treatment of ischemic conditions and conditions related to mitochondrial function |
| 02/22/2012 | EP2418948A1 Antiadhesion agents |
| 02/22/2012 | EP2418947A1 Bleached dextrin and methods of forming the same |
| 02/22/2012 | EP2418945A1 Mineral salt-sulfonic acid compositions and methods of use |
| 02/22/2012 | EP2418943A1 Curcumin analogs as dual jak2/stat3 inhibitors and methods of making and using the same |
| 02/22/2012 | EP2418942A1 Naphthalene-based inhibitors of anti-apoptotic proteins |
| 02/22/2012 | EP2326644B1 Urotensin ii receptor antagonists |
| 02/22/2012 | EP2323646B1 Use of steroid sulfatase inhibitors for the treatment of preterm labor |
| 02/22/2012 | EP2310382B1 Amidophenoxyindazoles useful as inhibitors of c-met |
| 02/22/2012 | EP2300479B1 Nalmefene hydrochloride dihydrate |
| 02/22/2012 | EP2285367B1 Pharmaceutical compositions for the treatment of warts |
| 02/22/2012 | EP2245028B1 5-aminocyclylmethyl-oxazolidin-2-one derivatives |
| 02/22/2012 | EP2234992B1 Piperazine derivatives and their use as leptin receptor modulators |
| 02/22/2012 | EP2152709B1 Morphinan compounds |
| 02/22/2012 | EP2099806B1 Spiropiperidine derivatives as nk3 antagonists |
| 02/22/2012 | EP2093228B1 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 02/22/2012 | EP2091520B1 Oral dosage form comprising tri-substituted glycerol compounds |
| 02/22/2012 | EP2086995B1 Hepatitis c virus inhibitors |
| 02/22/2012 | EP2076497B1 Aminomethyl-4-imidazoles |
| 02/22/2012 | EP1995240B1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 02/22/2012 | EP1963292B1 Organic compounds |
| 02/22/2012 | EP1948237B8 USE OF ß-1,3 (4)-ENDOGLUCANOHYDROLASE, ß-1,3 (4) GLUCAN, DIATOMACEOUS EARTH, MINERAL CLAY AND GLUCOMANNAN TO AUGMENT IMMUNE FUNCTION |
| 02/22/2012 | EP1937666B1 Substituted heterocyclic compounds with cxcr3 antagonist activity |
| 02/22/2012 | EP1937274B1 Use of estradiol valerate combined with dienogest for oral therapy of dysfunctional uterine bleeding in the form of oral contraceptives |
| 02/22/2012 | EP1906977B1 Stabilized chlorite solutions in combination with fluoropyrimidines for cancer treatment. |
| 02/22/2012 | EP1901776B1 Novel medicinal combinations which are used for treating respiratory tract diseases and contain beta-2 long-acting agonists and at least one other type of active substance |
| 02/22/2012 | EP1891216B1 Hybrid interfering rna |
| 02/22/2012 | EP1891071B1 Cyclopropanecarboxylate esters of acyclovir |
| 02/22/2012 | EP1890706B1 Process for the preparation and isolation of phosphatides |
| 02/22/2012 | EP1888174B1 Use of chalcones for the treatment of viral disorders |
| 02/22/2012 | EP1853280B1 Compositions and methods for treating and preventing cardiomyopathy and heart disease |
| 02/22/2012 | EP1841750B1 Heterocyclic modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof |
| 02/22/2012 | EP1805510B1 Therapeutic strategy for treating autoimmune and degenerative diseases |
| 02/22/2012 | EP1786405B1 Use and compounds for perceiving or controlling alcool intake |
| 02/22/2012 | EP1778637B1 FKBP-binding composition and pharmaceutical use thereof |
| 02/22/2012 | EP1765420B1 Sanitizing composition |
| 02/22/2012 | EP1677797B1 Salts and polymorphs of a potent antidiabetic compound |
| 02/22/2012 | EP1668013B1 Pyrazolopyrrole derivatives as protein kinase inhibitors |
| 02/22/2012 | EP1660440B1 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 02/22/2012 | EP1658073B1 Pharmaceutical product for injection |
| 02/22/2012 | EP1633387B1 Combinations of tumor-associated antigens for the treatment of various types of cancers |
| 02/22/2012 | EP1626049B1 Microcrystal of (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione |
| 02/22/2012 | EP1613740B1 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains |
| 02/22/2012 | EP1608767B1 Optimized expression of hpv 31 l1 in yeast |
| 02/22/2012 | EP1590328B1 (2-carboxamido) (3-amino) thiophene compounds |
| 02/22/2012 | EP1575566B1 Multilayer dosage forms containing naproxen and triptans |
| 02/22/2012 | EP1567007B1 Compositions and methods for cancer diagnosis and therapy |
| 02/22/2012 | EP1558226B1 Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics |
| 02/22/2012 | EP1541151B1 REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDINS |
| 02/22/2012 | EP1534680B1 Prenylation inhibitors and methods of their synthesis and use |
| 02/22/2012 | EP1534289B2 Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus |
| 02/22/2012 | EP1524975B9 Improved transdermal delivery system for the administration of rotigotine |
| 02/22/2012 | EP1514542B1 Medicinal composition comprising Tacrine or Donepezil for improving brain function. |
| 02/22/2012 | EP1509231B1 System for peritoneal dialysis comprising a reservoir of dialysis solution and a cartridge containing taurolidine powder |
| 02/22/2012 | EP1507778B1 Anti-tumour polycyclic carboxamides |
| 02/22/2012 | EP1389121B1 Method and compositions for treating mammalian nerve tissue injuries |
| 02/22/2012 | EP1163029B1 Nitrate esters and their use for inducing neuroprotection and cognition enhancement |
| 02/22/2012 | EP0986384B1 Inhibitors of protein isoprenyl transferases |
| 02/22/2012 | EP0979080B9 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 02/22/2012 | CN202146449U 装有洛匹那韦片和利托那韦片剂胶囊 Equipped with lopinavir and ritonavir tablet tablets Capsules |
| 02/22/2012 | CN202146448U 具有降血糖、血脂功效的茶色素胶囊 Tea pigment capsule has a hypoglycemic, lipid efficacy |
| 02/22/2012 | CN1939420B 一种新的抗菌抗病毒药物组合物及其制备方法 A new antibacterial antiviral composition and preparation method |
| 02/22/2012 | CN102361985A Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene |
| 02/22/2012 | CN102361981A Synthetic RNA-based agonists of TLR7 |
| 02/22/2012 | CN102361951A Base material for spraying comprising low-molecular gelling agent |
| 02/22/2012 | CN102361877A Thienopyrimidinedione derivatives as trpa1 modulators |
| 02/22/2012 | CN102361876A Bicyclic heterocyclic spiro compounds |
| 02/22/2012 | CN102361875A 2-hydroxyethyl-1h-quinolin-2-one derivatives and their azaisosteric analogues with antibacterial activity |
| 02/22/2012 | CN102361874A Furopyrimidinedione derivatives as trpa1 modulators |
| 02/22/2012 | CN102361873A Fused pyrimidine-dione derivatives as trpa1 modulators |
| 02/22/2012 | CN102361872A Fused pyrimidines as AKT inhibitors |
| 02/22/2012 | CN102361870A Propane- i-sulfonic acid {3- [5- (4 -chloro-phenyl) -1h-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof |
| 02/22/2012 | CN102361869A Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases |
| 02/22/2012 | CN102361868A Pyrazole-i, 2, 4 -oxad iazole derivatives as s.phing0sine-1-ph0sphate agonists |
| 02/22/2012 | CN102361867A Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases |
| 02/22/2012 | CN102361865A 3-benzofuranyl-indol-2-one derivatives substituted at the 3 position, preparation thereof, and therapeutic use thereof |
| 02/22/2012 | CN102361864A Substituted 3-benzofuranyl-indol-2-one-3-acetamididopiperazine derivatives, preparation thereof, and therapeutic use thereof |
| 02/22/2012 | CN102361863A Novel bicyclic antibiotics |
| 02/22/2012 | CN102361862A Thiophenyl sulfonamides for the treatment of alzheimer's disease |
| 02/22/2012 | CN102361860A Benzothiadiazepine derivatives used as AMPA and NMDA receptor modulators |
| 02/22/2012 | CN102361859A Heteroaryl compounds useful as Raf kinase inhibitors |
| 02/22/2012 | CN102361857A Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| 02/22/2012 | CN102361856A Modulators of cystic fibrosis transmembrane conductance regulator |